Pfizer's Next 3 Years: What Investors Can Expect

Pfizer (NYSE: PFE) delivered one of its strongest performances in a long time last year. Its stock jumped more than 20% in 2018, handily beating the broader market indexes. The big pharma company capped off the year with a solid fourth quarter that beat Wall Street estimates.